Chitosan nanoparticles/cellulose nanocrystals nanocomposites as a carrier system for the controlled release of repaglinide

International Journal of Biological Macromolecules

Volumn 111, Issue , 2018, Pages 604-613

  Abo Elseoud, Wafaa S ^a   Hassan, Mohammad L ^a,b   Sabaa, Magdy W ^c   Basha, Mona ^a   Hassan, Enas A ^a   Fadel, Shaimaa M ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

^c CAIRO UNIVERSITY   (Egypt)

Author keywords

Cellulose nanocrystals; Chitosan nanoparticles; Controlled release; Palm fruit stalks; Repaglinide

Indexed keywords

CELLULOSE NANOCRYSTAL; CHITOSAN; CHITOSAN NANOPARTICLE; NANOCRYSTAL; REPAGLINIDE; UNCLASSIFIED DRUG; CARBAMIC ACID DERIVATIVE; CELLULOSE; DRUG CARRIER; NANOCOMPOSITE; NANOPARTICLE; PIPERIDINE DERIVATIVE;

ARECACEAE; ARTICLE; CHEMICAL MODIFICATION; CHEMICAL REACTION; CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; GELATION; INFRARED SPECTROSCOPY; NANOENCAPSULATION; NANOFABRICATION; OXIDATION; PARTICLE SIZE; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG RELEASE; HUMAN; HYDROLYSIS; HYPERGLYCEMIA;

CARBAMATES; CELLULOSE; CHITOSAN; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG LIBERATION; HUMANS; HYDROLYSIS; HYPERGLYCEMIA; NANOCOMPOSITES; NANOPARTICLES; PIPERIDINES; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 85041401117     PISSN: 01418130     EISSN: 18790003     Source Type: Journal    
DOI: 10.1016/j.ijbiomac.2018.01.044     Document Type: Article

References (53)

1. Jain, S.K., Awasthi, A.M., Jain, N.K., Agrawal, G.P., Calcium silicate based microspheres of repaglinide for gastroretentive floating drug delivery: preparation and in vitro characterization. J. Control. Release 107 (2005), 300–309.
2. Kulkarni, R.V., Patel, F.S., Nanjappaiah, H.M., Naikawadi, A.A., In vitro and in vivo evaluation of novel interpenetrated polymer network microparticles containing repaglinide. Int. J. Biol. Macromol. 69 (2014), 514–522.
3. Lokhande, A.B., Mishra, S., Kulkarni, R.D., Naik, J.B., Preparation and characterization of repaglinide loaded ethylcellulose nanoparticles by solvent diffusion technique using high pressure homogenizer. J. Pharm. Res. 7 (2013), 421–426.
4. Sunasee, R., Hemraz, U.D., Ckless, K., Cellulose nanocrystals: a versatile nanoplatform for emerging biomedical applications. Expert Opin. Drug Deliv. 13 (2016), 1243–1256.
5. Baumann, M., Kang, C., Stanwick, J., Wang, Y., Kim, H., Lapitsky, Y., Shoichet, M., An injectable drug delivery platform for sustained combination therapy. J. Control. Release 138 (2009), 205–213.
6. Abdalla, A., Klein, S., Mäder, K., A new self-emulsifying drug delivery system (SEDDS) for poorly soluble drugs: characterization, dissolution, in vitro digestion and incorporation into solid pellets. Eur. J. Pharm. Sci. 35 (2008), 457–464.
7. Lin, N., Cellulose Nanocrystals: Surface Modification and Advanced Materials Cellulose Nanocrystals: Surface Modification and Advanced Materials. 2016, Grenoble Alpes University, France.
8. Jain, S.K., Sahu, A.K., Mohan, P.K., Jain, Ion exchange resins- pharmaceutical and clinical applications: review. Asian J. Biomater. Res. 2 (2016), 51–61.
9. Mohanta, V., Madras, G., Patil, S., Layer-by-layer assembled thin films and microcapsules of nanocrystalline cellulose for hydrophobic drug delivery. ACS Appl. Mater. Interfaces 6 (2014), 20093–20101.
10. Jackson, J.K., Letchford, K., Wasserman, B.Z., Ye, L., Hamad, W.Y., Burt, H.M., The use of nanocrystalline cellulose for the binding and controlled release of drugs. Int. J. Nanomedicine 6 (2011), 321–330.
11. Dong, S., Cho, H.J., Lee, Y.W., Roman, M., Synthesis and cellular uptake of folic acid-conjugated cellulose nanocrystals for cancer targeting. Biomacromolecules 15 (2014), 1560–1567.
12. Rescignano, N., Fortunati, E., Armentano, I., Hernandez, R., Mijangos, C., Pasquino, R., Kenny, J.M., Use of alginate, chitosan and cellulose nanocrystals as emulsion stabilizers in the synthesis of biodegradable polymeric nanoparticles. J. Colloid Interface Sci. 445 (2015), 31–39.
13. Garcia-Fuentes, M., Alonso, M.J., et al. J. Control. Release 161 (2012), 496–504.
14. Gao, L., Liu, G.Y., Ma, J.L., Wang, X.Q., Zhou, L., Li, X., Wang, F., Application of drug nanocrystal technologies on oral drug delivery of poorly soluble drugs. Pharm. Res. 30 (2013), 307–324.
15. Ige, P.P., Baria, R.K., Gattani, S.G., Fabrication of fenofibrate nanocrystals by probe sonication method for enhancement of dissolution rate and oral bioavailability. Colloids Surf. B Biointerfaces 108 (2013), 366–373.
16. Jinno, J., Kamada, N., Miyake, M., Yamada, K., Mukai, T., Odomi, M., Toguchi, H., Liversidge, G.G., Higaki, K., Kimura, T., Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs. J. Control. Release 111 (2006), 56–64.
17. Müller, R.H., Gohla, S., Keck, C.M., State of the art of nanocrystals - special features, production, nanotoxicology aspects and intracellular delivery. Eur. J. Pharm. Biopharm. 78 (2011), 1–9.
18. Van Gaal, L.F., Van Acker, K.L., De Leeuw, I.H., Repaglinide improves blood glucose control in sulphonylurea-naive type 2 diabetes. Diabetes Res. Clin. Pract. 53 (2001), 141–148.
19. Fuhlendorff, J., Rorsman, P., Kofod, H., CL, B., Rolin, B., MacKay, P., Shymko, R., RD, C., Stimulation of insulin release by repaglinide and glibenclamide involves\rboth common and distinct processes. Diabetes, 47, 1998, 345.
20. Cuna, M., Alonso, M.J., Torres, D., Preparation and in vivo evaluation of mucoadhesive microparticles containing amoxycillin-resin complexes for drug delivery to the gastric mucosa. Eur. J. Pharm. Biopharm. 51 (2001), 199–205.
21. Adam, Z., Hamid, M., Ismail, A., Khamis, S., Effect of Ficus deltoidea aqueous extract on blood glucose level in normal and mild diabetic rats. J. Sains Kesihat. Malaysia. 5 (2007), 9–16.
22. Poovi, G., Dhana Lekshmi, U.M., Narayanan, N., Preparation and characterization of repaglinide loaded chitosan polymeric nanoparticles. Res. J. Nanosci. Nanotechnol. 1 (2011), 12–24.
23. Akhlaghi, S.P., Tiong, D., Berry, R.M., Tam, K.C., Comparative release studies of two cationic model drugs from different cellulose nanocrystal derivatives. Eur. J. Pharm. Biopharm. 88 (2014), 207–215.
24. Akhlaghi, S.P., Tiong, D., Berry, R.M., Tam, K.C., Comparative release studies of two cationic model drugs from different cellulose nanocrystal derivatives. Eur. J. Pharm. Biopharm. 88 (2014), 207–215.
25. Wang, H., Qian, C., Roman, M., Effects of pH and salt concentration on the formation and properties of chitosan-cellulose nanocrystal polyelectrolyte-macroion complexes. Biomacromolecules 12 (2011), 3708–3714.
26. Browning, B.L., Methods of Wood Chemistry. 2, 1967.
27. Hassan, M.L., Bras, J., Hassan, E.A., Silard, C., Mauret, E., Enzyme-assisted isolation of microfibrillated cellulose from date palm fruit stalks. Ind. Crop. Prod. 55 (2014), 102–108.
28. Hassan, M.L., Abou-Zeid, R.E., Fadel, S.M., El-Sakhawy, M., Khiari, R., Cellulose nanocrystals and carboxymethyl cellulose from olive stones and their use to improve paper sheets properties. Int. J. Nanoparticles 7 (2014), 261–277.
29. Habibi, Y., Chanzy, H., Vignon, M.R., TEMPO-mediated surface oxidation of cellulose whiskers. Cellulose 13 (2006), 679–687.
30. Calvo, P., RemunanLopez, C., VilaJato, J.L., Alonso, M.J., Remuñan-López, C., Vila-Jato, J.L., Alonso, M.J., Chitosan and chitosan ethylene oxide propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines. Pharm. Res. 14 (1997), 1431–1436.
31. Sidiras, D.K., Koullas, D.P., Vgenopoulos, A.G., Koukios, E.G., Cellulose crystallinity as affected by various technical processes. Cellul. Chem. Technol. 24 (1990), 309–317.
32. Holm, R., Müllertz, A., Christensen, E., Høy, C.E., Kristensen, H.G., Comparison of total oral bioavailability and the lymphatic transport of halofantrine from three different unsaturated triglycerides in lymph-cannulated conscious rats. Eur. J. Pharm. Sci. 14 (2001), 331–337.
33. Muthu, M.S., Singh, S., Studies on biodegradable polymeric nanoparticles of risperidone: in vitro and in vivo evaluation. Nanomedicine 3 (2008), 305–319.
34. Lobo, M.S., Costa, P., Modeling and comparison of dissolution pro les.PDF. Eur. J. Pharm. Sci. 13 (2001), 123–133.
35. Zugenmaier, P., Crystalline cellulose and derivatives. Timell, T.E., Wimmer, R.W., (eds.) Crystalline Cellulose and Cellulose Derivatives. Characterization and Structure, 2008, Springer-Verlag, Berlin, Heidelberg, 1–281.
36. Abou-Zeid, R.E., Hassan, E.A., Bettaieb, F., Khiari, R., Hassan, M.L., Use of cellulose and oxidized cellulose nanocrystals from olive stones in chitosan bionanocomposites. J. Nanomater., 2015, 2015.
37. Ivanova, N.V., Korolenko, E.A., Korolik, E.V., Zhbankov, R.G., IR spectrum of cellulose. J. Appl. Spectrosc. 51 (1989), 847–851.
38. Seleim, W., Preparation and Characterization of Cellulosic Bionanocomposites Using Local Agricultural Residues. (Master thesis), 2013, Zagazig University, Egypt http://db4.eulc.edu.eg/eulc_v5/Libraries/Thesis/BrowseThesisPages.aspx?fn=PublicDrawThes.
39. De Mesquita, J.P., Donnici, C.L., Pereira, F.V., Biobased nanocomposites from layer-by-layer assembly of cellulose nanowhiskers with chitosan. Biomacromolecules 11 (2010), 473–480.
40. Wan, Y., Creber, K.A.M., Peppley, B., Bui, V.T., Synthesis, characterization and ionic conductive properties of phosphorylated chitosan membranes. Macromol. Chem. Phys. 204 (2003), 850–858.
41. Bhumkar, D.R., Pokharkar, V.B., Studies on effect of pH on cross-linking of chitosan with sodium tripolyphosphate: a technical note. AAPS PharmSciTech 7 (2006), E138–E143, 10.1208/pt070250.
42. Leroueil-Le Verger, M., Fluckiger, L., Kim, Y.-I., Hoffman, M., Maincent, P., Preparation and characterization of nanoparticles containing an antihypertensive agent. Eur. J. Pharm. Biopharm. 46 (1998), 137–143.
43. Kassem, A.A., Abd El-Alim, S.H., Basha, M., Salama, A., Phospholipid complex enriched micelles: a novel drug delivery approach for promoting the antidiabetic effect of repaglinide. Eur. J. Pharm. Sci. 99 (2017), 75–84.
44. He, W., Wu, M., Huang, S., Yin, L., Matrix tablets for sustained release of repaglinide: preparation, pharmacokinetics and hypoglycemic activity in beagle dogs. Int. J. Pharm. 478 (2015), 297–307.
45. Zhang, Y., Shi, Y., Yu, X., Song, Y., Study on the preparation of repaglinide chitosan microspheres with genipin. Adv. Mater. Res., 2013, 252–255.
46. Ebrahimi, H.A., Javadzadeh, Y., Hamidi, M., Barzegar Jalali, M., Development and characterization of a novel lipohydrogel nanocarrier: repaglinide as a lipophilic model drug. J. Pharm. Pharmacol. 68 (2016), 450–458.
47. Elmowafy, E., Osman, R., El-Shamy, A.E.-H.A., Awad, G.A., Stable colloidal chitosan/alginate nanocomplexes: fabrication, formulation optimization and repaglinide loading, Int. J. Pharm. Pharm. Sci. 6 (2014), 520–525.
48. Elmowafy, E., Osman, R., El-Shamy, A.E.-H.A., Awad, G.A., Nanocomplexes of an insulinotropic drug: optimization, microparticle formation, and antidiabetic activity in rats. Int. J. Nanomedicine 9 (2014), 4449–4465.
49. Vijayan, V., Reddy, K.R., Sakthivel, S., Swetha, C., Optimization and charaterization of repaglinide biodegradable polymeric nanoparticle loaded transdermal patchs: in vitro and in vivo studies. Colloids Surf. B Biointerfaces 111 (2013), 150–155.
50. Das, C., Sajeeth, C.I., Design, development and evaluation of mucoadhesive patches of repaglinide for buccal delivery. Int. J. Pharm. Technol. 5 (2013), 5271–5288.
51. Vaghani, S.S., Patel, M.M., Hydrogels based on interpenetrating network of chitosan and polyvinyl pyrrolidone for pH-sensitive delivery of repaglinide. Curr. Drug Discov. Technol. 8 (2011), 126–135.
52. Yadav, V.K., Kumar, B., Prajapati, S.K., Shafaat, K., Design and evaluation of mucoadhesive microspheres of repaglinide for oral controlled release. Int. J. Drug Deliv. 1 (2011), 357–370.
53. Korsmeyer, R.W., Gurny, R., Doelker, E., Buri, P., Peppas, N.A., Mechanism of release from porous hydrophilic polymers. Int. J. Pharm. 15 (1983), 25–35.